Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.

Resource Library

IV & SQ Treprostinil: Challenges and Solutions

Stephanie Harris


Juliana Liu


Reviews

  Sign in to add a review

0 comments
Leave a Comment

Conference: 2007 PH Resource Network Symposium

Release Date: 10.12.2007

Presentation Type: Breakout Sessions

File Download: 2007 Symposium Remodulin

Download Adobe Acrobat

Jugular Venous Pressure

New treatment options provide improved health outcomes for patients, but how do they compare with more established treatments? Intravenous and subcutaneous Remodulin (treprostinil), approved by the FDA in 2002, will be reveiwed and compared with the first of the prostacyclins, Flolan (epoprostenol). Specific challenges and solutions of IV and SQ Remodulin treatment will also be covered, such as line infections, site pain and transitions.